Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
|
Turnaround Potential
1321.7000
-1.00
(
-0.08
%)
NSE
Sep 19, 2025
15:31 PM
29.58% Gain from 52W Low
Volume:
1.4M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
edited
01 Dec 2020
1321.70
-0.08%
Dr. Reddys And RDIF Commence Clinical Trials For Sputnik V Vaccine In India
NDTV Profit
The clinical trials are being conducted by JSS Medical Research as the clinical research partner
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
Dr Reddy's Laboratories shares gain as firm commences clinical trials for Sputnik V vaccine
Moneycontrol |
02 Dec 2020
4 more
DRL, RDIF commence clinical trials for Sputnik V Covid-19 vaccine in India
Business Standard |
02 Dec 2020
Covid-19 vaccine: Dr Reddy's, RDIF begin trials for Sputnik V in India
Business Line |
01 Dec 2020
Dr Reddy's, RDIF commence clinical trials for Sputnik V vaccine in India
Business Line |
01 Dec 2020
Dr Reddy's Labs Starts Clinical Trials Of Sputnik V Vaccine; Stock Firm
NDTV Profit |
02 Dec 2020
More from Dr. Reddy's Laboratories Ltd.
Recommended
Five Interesting Stocks Today - September 19, 2025
The Baseline |
19 Sep 2025, 04:31PM
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch |
19 Sep 2025, 03:58PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021